• Home
  • About us
  • Contact us
  • Subscribe
  • For Authors
  • For Advertisers
  • Company Listings A-Z
  • Events
Login Here


Register
 


 Russell Publishing Ltd
 Court Lodge
 Hogtrough Hill
 Brasted
 Kent TN16 1NU. UK
 Registered in England 
 No. 2709148
 Registered office as above.
 VAT No. GB 577 897847

 

The role of chemokines in type 1 diabetes: as assessed by RT-PCR

publication date: Mar 19, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Type 1 diabetes is an autoimmune disease, characterised by immune infiltration into the islets of Langerhans, resulting in the destruction of insulin producing b-cells. Over recent years, evidence has been collected on the important role of chemokines in the recruitment of immune cells leading to the pathology of this disease. In this review we discuss the findings on the role of chemokines, as obtained from animal studies. We will focus on the quantification of chemokines and chemokine receptors, making use of the innovative real-time quantitative PCR technique.



Sorry, this page is available to subscribers only.

If you have not registered with us yet, why not register today for FREE.

Interested in receiving European Pharmaceutical Review in print? Subscribe today and guarantee the next six issues delivered direct to your desk, plus gain exclusive access online.


Why should I register online with European Pharmaceutical Review?

* To access the latest Editor's pick of articles

* The opportunity to add and view comments on the latest Editor's pick of articles

* View all the latest news

Why should I subscribe to European Pharmaceutical Review?

* To receive European Pharmaceutical Review in print (6 times a year)

* To gain access to European Pharmaceutical Review Digital online and by email

* Access to all current and past articles online

* The opportunity to add and view comments on articles

* View all the latest news